
The MiniMed 780G Insulin Pump System is an advanced automated insulin-delivery system that uses SmartGuard technology to adjust basal insulin and deliver automatic correction doses every five minutes based on compatible continuous glucose monitoring data. With adjustable glucose targets as low as 100 mg/dL, smartphone data viewing, and compatibility with select MiniMed CGM sensors, the system is designed to help eligible users manage insulin therapy with greater automation.
The MiniMed 780G System is a prescription automated insulin-delivery system designed to continuously deliver rapid-acting insulin and help manage changing glucose levels throughout the day and night.
When SmartGuard technology is active, the system receives glucose data from a compatible continuous glucose monitor and automatically evaluates insulin needs every five minutes. It can adjust basal insulin delivery and provide automatic correction doses when needed, helping reduce some of the manual calculations involved in traditional insulin-pump therapy.
The system offers adjustable glucose targets, including a target as low as 100 mg/dL, allowing qualified healthcare professionals to personalize therapy according to the individual user’s needs.
The MiniMed 780G pump can display insulin-delivery and glucose information directly on the pump. A compatible smartphone application may also allow users and approved care partners to view pump and glucose information, depending on device compatibility and system configuration.
The MiniMed 780G is a complex prescription medical system and requires professional setup, individualized programming, and formal training before use.
The exact MiniMed 780G package varies according to the prescription, distributor, insurance authorization, and selected CGM configuration.
A system package may include:
Do not state that every sensor, transmitter, infusion set, meter, or accessory is included unless confirmed for the specific package being dispensed.
Under current U.S. labeling, the MiniMed 780G System is intended for:
The SmartGuard feature should not be used by individuals requiring less than 8 units or more than 250 units of total daily insulin.
A healthcare professional must determine whether the system is appropriate for each patient.